Company intelligence / Profile preview
Excell Biotech
Clearwater, Florida, United Statesexcellbio.io ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Excell Biotech was a private U.S. biotechnology startup based in Clearwater, Florida focused on genomics-based therapeutics for viral infection and immune disease. Public materials described the company as developing vaccines and gene therapies, with its lead disclosed program being EXD-12, a live attenuated herpes simplex virus vaccine in preclinical development. The company also described earlier-stage oncology work intended to restore p53 activity in cancer cells and broader gene therapy ambitions for genetic diseases. Third-party company databases later classified the company as inactive or deadpooled, suggesting operations have ceased.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- VaccineGene therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Excell Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Excell Biotech.